RSV lower respiratory tract infection prevention
Vaccines · 2024–2024
1decision
1medicine
1carried consumer input
0individual submissions
Every decision
| Medicine | Meeting | Outcome | Consumer input |
|---|---|---|---|
| recombinant syncytial pre-fusion F protein vaccine Prevention of lower respiratory tract illness (LRTI) caused by respiratory syncytial virus (RSV) in infants from birth through 6 months of age by active… | May 2024 | Not recommended | input received Immunisation Foundation · Lung Foundation Australia · CreakyJoints Australia · Global Healthy Living Foundation Australia |
Who spoke
Immunisation Foundation · Lung Foundation Australia · CreakyJoints Australia · Global Healthy Living Foundation Australia
Conditions are classified by a language model from the indication text of each submission, so an individual label here can be wrong. Consumer input is read from the document's own consumer comments section: 1 of 1 decisions since 2014 carried some. Silence means no comment reached the committee through that facility, not that nobody was affected. More on how this was built.